The White House is shaking up the vaccine world again — this time over aluminum. In this Episode 466 interview, Del Bigtree sits down with Brian Hooker, PhD, and board-certified emergency and integrative physician James Neuenschwander, MD, to unpack their landmark 2026 paper: “Aluminum Adjuvants, Autoimmunity and Autism Spectrum Disorder: A Comprehensive Mechanistic, Neuropathological and Legal Analysis.”

The paper reviewed approximately 700 references to build a mechanistic case connecting aluminum nanoparticle adjuvants in childhood vaccines to immune activation, NLRP3 inflammasome-driven neuroinflammation, mitochondrial damage, disrupted synaptic pruning, and the development of autism spectrum disorder. Hooker and Neuenschwander walk through the biological pathway step by step — from injection site to white blood cell uptake to brain trafficking — and explain how they applied all nine Bradford Hill criteria to argue for causation rather than mere correlation.

The conversation also covers why aluminum nanoparticles in vaccines behave differently from dietary aluminum, the role of autoimmune encephalitis found in 64% of autistic brain autopsy studies, the cumulative aluminum load from the current childhood vaccine schedule, and what changing adjuvants or restructuring the schedule could mean. Dr. Hooker shares why he considers this the most important work of his career, and both guests discuss the broader scientific and political debate around vaccine safety under the current HHS administration.

AIRDATE: March 5, 2026